March 2018
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis - PRECISION Study
V. Kasivisvanathan, A.S. Rannikko, M. Borghi, V. Panebianco, L.A. Mynderse, M.H. Vaarala, A. Briganti, L. Budäus, G. Hellawell, R.G. Hindley, M.J. Roobol, S. Eggener, M. Ghei, A. Villers, F. Bladou, G.M. Villeirs, J. Virdi, S. Boxler, G. Robert, P.B. Singh, W. Venderink, B.A. Hadaschik, A. Ruffion, J.C. Hu, D. Margolis, S. Crouzet, L. Klotz, S.S. Taneja, P. Pinto, I. Gill, C. Allen, F. Giganti, A. Freeman, S. Morris, S. Punwani, N.R. Williams, C. Brew‑Graves, J. Deeks, Y. Takwoingi, M. Emberton, and C.M. Moore, for the PRECISION Study Group Collaborators: MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis - PRECISION Study. N Engl J Med 2018; 378:1767-1777
April 2016
Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?
Narayanan, R. ; Kurhanewicz, J. ; Shinohara, K. ; Crawford, E.D.: MRI-ultrasound registration for targeted prostate biopsy. EEE International Symposium on Kamrava M, Hegde JV, Abgaryan N, Chang E, Le JD, Wang J, Kupelian PA, Marks LS, University of California, Irvine, CA: Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists? BJU Int. 2016 Apr;117(4):584-91. doi: 10.1111/bju.13082. Epub 2015 May 4.
March 2016
Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes
Meng X, Rosenkrantz AB, Mendhiratta N, Fenstermaker M, Huang R, Wysock JS, Bjurlin MA, Marshall S, Deng FM, Zhou M, Melamed J, Huang WC, Lepor H, Taneja SS, New York University, New York NY: Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes. Eur Urol. 2016 Mar; 69(3):512-7. doi: 10.1016/j.eururo.2015.06.005. Epub 2015 Jun 22.
December 2015
Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification
Mendhiratta N, Rosenkrantz AB, Meng X, Wysock JS, Fenstermaker M, Huang R, Deng FM, Melamed J, Zhou M, Huang WC, Lepor H, Taneja SS, New York University, New York NY: Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification. J Urol. 2015 Dec;194(6):1601-6. doi: 10.1016/j.juro.2015.06.078. Epub 2015 Jun 19.
September 2015
Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis
Ivo G. Schoots, Monique J. Roobol, Daan Nieboer Chris H. Bangma, Ewout W. Steyerberg, M.G. Myriam Hunink: Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol, 2015. 68(3): p. 438-50.
July 2015
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review
Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, Mozer P, Rastinehad AR, Ahmed HU: Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. Eur Urol. 2015 Jul;68(1):8-19.
March 2013
Value of Targeted Prostate Biopsy using MR-US Fusion in Men with Prior Negative Biopsy and Elevated PSA
Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, and Marks LS: Value of Targeted Prostate Biopsy using MR-US Fusion in Men with Prior Negative Biopsy and Elevated PSA. European Urology. March 17, 2013.